SCHEDULE 13G
CUSIP NO. 000000000 PAGE 15 OF 16 PAGES
Exhibit I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the
amendment to Schedule 13G filed with the Securities and Exchange Commission on
or about the date hereof with respect to the beneficial ownership by the
undersigned of the Common Stock, $.01 par value, of Viragen, Inc., a Delaware
corporation, is being filed, and all amendments thereto will be filed, on behalf
of each of the persons and entities named below in accordance with Rule 13d-1(k)
under the Securities Exchange Act of 1934, as amended. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.
Dated as of October 6, 2005
OMICRON MASTER TRUST
By: OMICRON CAPITAL, L.P.,
Investment Manager
By: OMICRON CAPITAL, INC.,
General Partner
By: /s/ Xxxxxxx X. Xxxxxx
----------------------------
Xxxxxxx X. Xxxxxx
Title: President
OMICRON CAPITAL, L.P.
By: OMICRON CAPITAL, INC.,
General Partner
By: /s/ Xxxxxxx X. Xxxxxx
----------------------------
Xxxxxxx X. Xxxxxx
Title: President
OMICRON CAPITAL, INC.
By: /s/ Xxxxxxx X. Xxxxxx
----------------------------
Xxxxxxx X. Xxxxxx
Title: President
SCHEDULE 13G
CUSIP NO. 000000000 PAGE 16 OF 16 PAGES
/s/ Xxxxx Xxxxxxxxx
----------------------------
Xxxxx Xxxxxxxxx
/s/ Xxxxxxx X. Xxxxxx
----------------------------
Xxxxxxx X. Xxxxxx
WINCHESTER GLOBAL TRUST COMPANY LIMITED
By: /s/ Xxxxx X. Lewnowksi
----------------------------
Xxxxx X. Xxxxxxxxx
Title: Chairman
/s/ Xxxxx X. Lewnowksi
----------------------------
Xxxxx X. Xxxxxxxxx
